Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Acta Pharmaceuticals closes $24 million in Seed financing to advance its Alzheimer’s disease pipeline focused on early intervention and prevention.

PRIVATEOct 15, 2026

Amount Raised

$24 Million

Round Type

Seed

BostonBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Acta Pharmaceuticals has successfully closed a $24 million Seed financing round. The funding will support their Alzheimer’s disease pipeline, specifically targeting early intervention and prevention strategies. Additionally, the company will commence a phase 1 study for GSM-779690T. This financing marks a significant step in Acta's ongoing research efforts.

Company Information

Company

Acta Pharmaceuticals

Location

Boston, Massachusetts, United States

About

Acta Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for Alzheimer's disease. The company aims to address early intervention and prevention strategies in treating this condition. Acta's lead compound, GSM-779690T, is currently entering phase 1 studies. Their goal is to provide new hope for patients and families affected by Alzheimer's.

Fundz sees it the moment Acta Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Acta Pharmaceuticals's next move

See what Strategic adds

Acta Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.